Vaccine Development and Production
The term, “vaccination” (from the Latin vacca, meaning cow) was first introduced by Edward Jenner in the late 18th century when he realized that milkmaids who acquired a pox-like disease from cows were resistant to smallpox virus infection.
After Jenner’s confirmed his hypothesis by infecting a young boy with milkmaid pus and challenging him with live smallpox virus, the new practice of immunization quickly spread across Europe.
The Challenges of Modern Vaccinology
The discipline of vaccinology has changed since then, but the term “vaccine” still refers to any preparation that specifically improves immunity to a disease. Nowadays, immunization strategies are less empirical and vaccine-associated mortalities are rare events. However, the drawback is that safer vaccines are often less immunogenic and multiple injections may thus be required to maintain protective antibody levels.
Today’s challenges in vaccine manufacture call for flexible solutions that can be up and running quickly and efficiently. Our vaccine manufacturing model, using disposable technologies, offers a number of significant advantages for fast and cost-efficient production.